Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jul-Aug;70(4):309-310.
doi: 10.1016/j.bjan.2020.07.001. Epub 2020 Jul 18.

[Tranexamic acid - choosing the best dose]

[Article in Portuguese]
Rodrigo Leal Alves  1
Affiliations
Editorial

[Tranexamic acid - choosing the best dose]

[Article in Portuguese]
Rodrigo Leal Alves. Braz J Anesthesiol. 2020 Jul-Aug.
No abstract available

PubMed Disclaimer

References

    1. Okamoto S., Okamoto U. Amino-Methyl-Cyclohexane-Carboxylic Acid: AMCHA. A new potent inhibitor of the fibrinolysis. Keio J Med. 1962;11:105–115.
    1. Guerriero C., Cairns J., Perel P., et al. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011;6 - PMC - PubMed
    1. Sudhof L.S., Shainker A.S., Einerson B.D. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: A cost-effectiveness analysis. Am J Obstet Gynecol. 2019;221:275. - PubMed
    1. CRASH-2 Trial Collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23–32. - PubMed
    1. WOMAN Trial Collaborators Effects of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–2116. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources